A systematic literature study spanning 8 years and integrating multiple databases to explore the evidence for a positive role of IL-6 inhibition in a variety of inflammatory diseases found no therapeutic effect of IL-6 inhibition in ankylosing spondylitis, psoriatic arthritis, and certain connective tissue diseases (35). Here, IL6 is linked to psoriatic arthritis.